Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

PHASE1CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2005

Conditions
Plasmodium Falciparum Malaria
Interventions
BIOLOGICAL

FMP1/AS02A Malaria vaccine

Subjects vaccinated with FMP1/AS02 vaccine

BIOLOGICAL

Imovax Rabies vaccine

Subjects vaccinated on corresponding FMP1/AS02A vaccination days

Trial Locations (1)

Unknown

Walter Reed Project Kombewa Clinic, Kombewa

All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

The PATH Malaria Vaccine Initiative (MVI)

OTHER

collaborator

United States Agency for International Development (USAID)

FED

collaborator

GlaxoSmithKline

INDUSTRY

lead

U.S. Army Medical Research and Development Command

FED